Skip to main content

Table 3 Impact of adjustments for estimated glomerular filtration rate (eGFR), aortic pulse wave velocity (PWV) or C-reactive protein (CRP) on the relative contribution of circulating resistin concentrations to variations in left ventricular mass index (LVMI) in a community sample (n = 647)

From: Associations between circulating resistin concentrations and left ventricular mass are not accounted for by effects on aortic stiffness or renal dysfunction

Models with→aa + eGFRa + PWVa + CRP
β-coeff ±SEMp valueβ-coeff±SEMp valueβ-coeff±SEMp valueβ-coeff±SEMp value
Age0.156 ± 0.048=0.00120.097 ± 0.056=0.090.111 ± 0.052=0.0280.155 ± 0.049=0.0015
Male gender0.030 ± 0.040=0.450.032 ± 0.040=0.420.032 ± 0.040=0.430.029 ± 0.041=0.47
Weight0.147 ± 0.039=0.00020.148 ± 0.039=0.00020.153 ± 0.039=0.00010.150 ± 0.041=0.0002
SBP0.218 ± 0.041< 0.00010.211 ± 0.041< 0.00010.191 ± 0.043< 0.00010.212 ± 0.041< 0.0001
Log resistin0.090 ± 0.036=0.0140.075 ± 0.036=0.0440.084 ± 0.036=0.0220.087 ± 0.036=0.017
eGFR or PWV or CRP−0.098 ± 0.051=0.0520.102 ± 0.048=0.0470.004 ± 0.043=0.92
HOMA-IR0.094 ± 0.037=0.0120.082 ± 0.038=0.0320.090 ± 0.037=0.0170.096 ± 0.037=0.011
  1. β-coeff standardized β-coefficient, BMI body mass index, SBP office systolic blood pressure, HOMA-IR homeostasis model of insulin resistance. aAdditional factors included in the stepwise regression models include regular smoking, regular alcohol intake, treatment for hypertension and diabetes mellitus or an HbA1c > 6.5%